# Ayahuasca, Esketamine and PTSD

> **NCT07317206** · PHASE2 · RECRUITING · sponsor: **University of Sao Paulo** · enrollment: 10 (estimated)

## Conditions studied

- Posttraumatic Stress Disorder (PTSD)

## Interventions

- **DRUG:** Ayahuasca
- **DRUG:** Esketamine

## Key facts

- **NCT ID:** NCT07317206
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-20
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07317206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07317206, "Ayahuasca, Esketamine and PTSD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07317206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*